logo

PTHS

Pelthos Therapeutics·AMEX
--
--(--)
--
--(--)
4.67 / 10
Netural

With a fund flow rating of 7.49/10, the stock shows robust fund flow characteristics. Supportive momentum from Small and Extra-large trends is partially offset by concerning overall, block, Medium, and Large patterns, pointing to positive capital flow trajectory. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Buy(100.0%) based on 1 research evaluations, supported by 1.85 historical weighted rating.

FundamentalSentiment(4.67)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-26
InstitutionOppenheimer
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of PTHS?
  • PTHS holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.67/10 (Netural).